Search

Author/Creator Pulte, E. Dianne

3. Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses. Issue 8 (10th March 2022)

Authors:
Norsworthy, Kelly J.; Gao, Xin; Ko, Chia-Wen; Pulte, E. Dianne; Zhou, Jiaxi; Gong, Yutao; Shen, Yuan Li; Vallejo, Jonathon; Gwise, Thomas E.; Sridhara, Rajeshwari; Deisseroth, Albert B.; Farrell, Ann T.; de Claro, R. Angelo; Blumenthal, Gideon M.; Pazdur, Richard
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 8(2022)
Page Start:
847
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. U.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission. (24th April 2019)

Authors:
Pulte, E. Dianne; Wroblewski, Tanya; Bloomquist, Erik; Tang, Shenghui; Farrell, Ann; Deisseroth, Albert; McKee, Amy E.; Pazdur, Richard
Journal:
Oncologist
Issue:
Volume 24:Number 5(2019)
Page Start:
e188
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗